Market Price Volatility and Impairment Risk for Investment Securities
First written in FY2017. 16 of 25 entries say "Restated". Latest entry: FY2026.
Edion moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2019: 37 of 69 companies on the "Worse" side.
24 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「Consolidated fiscal year (1 April 2025 to 31 March 2026) There are no applicable matters.」
No impairment loss was recognized on investment securities in the current fiscal year, down from ¥12 million in the previous fiscal year. - FY2026-H1MitigatedAnnual report
「Impairment loss on investment securities 12 —」
The impairment loss on investment securities decreased from ¥12 million in the interim period of the previous year to zero in the current interim period. - FY2025MaterialisedAnnual report
「During the consolidated fiscal year, impairment losses of ¥12 million were recognized on securities, consisting of ¥12 million on shares classified as other securities.」
An impairment loss of ¥12 million was recognized on investment securities. - FY2025-H1MaterialisedAnnual report
「Impairment loss on investment securities — 12」
An impairment loss of ¥12 million on investment securities was recognized during the interim period, resulting in an impairment loss that had not occurred in the interim period of the previous year. - FY2024-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was determined that there had been no material change in the market price fluctuation and impairment risks associated with investment securities. - FY2024-Q2RestatedAnnual report
「No new business or other risks arose during the first half of the current consolidated fiscal year. In addition, no material changes have occurred in the business and other risks described in the securities report for the previous fiscal year.」
It was determined that there had been no material change in the market price fluctuation and impairment risks associated with investment securities. - FY2024-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was determined that there had been no material change in the market price fluctuation and impairment risks associated with investment securities. - FY2023-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was determined that there had been no material change in the market price fluctuation and impairment risks associated with investment securities. - FY2023-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was determined that there had been no material change in the market price fluctuation and impairment risks associated with investment securities. - FY2022MaterialisedAnnual report
「During the consolidated fiscal year, impairment losses of ¥7 million were recognized on securities, consisting of ¥7 million on shares classified as other securities.」
With respect to the market price fluctuation and impairment risks associated with investment securities, an impairment loss of ¥7 million was recognized on shares classified as other securities. - FY2022-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was determined that there had been no material change in the market price fluctuation and impairment risks associated with investment securities. - FY2022-Q2MaterialisedAnnual report
「Valuation loss on investment securities 16」
An impairment loss of ¥16 million on investment securities was recognized during the cumulative second-quarter period. - FY2022-Q1MaterialisedAnnual report
「Impairment loss on investment securities ¥17 million」
Recognized an ¥17 million valuation loss on investment securities during the cumulative first quarter. - FY2021RestatedAnnual report
「Investment securities consist mainly of shares in companies with which the Group has business relationships. Those with quoted market values are exposed to the risk of fluctuations in market prices, while those without quoted market values are exposed to the risk of impairment depending on the investee's operating results and other factors.」
Reconfirmed the risks of fluctuations in the market prices of investment securities and impairment resulting from the investees' operating results and other factors, as well as the regular monitoring of fair value and corporate value. - FY2020MaterialisedAnnual report
「During the current fiscal year, the Company recognized impairment losses of ¥53 million on securities, comprising ¥53 million on shares classified as other securities.」
Recognized ¥53 million in impairment losses on investment securities due to declines in market prices and other factors. - FY2020-Q2RestatedAnnual report
「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
Stated that there had been no new occurrence or material change in the risk of fluctuations in the market prices of investment securities or impairment. - FY2020-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
Stated that there had been no new occurrence or material change in the risk of fluctuations in the market prices of investment securities or impairment. - FY2019-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
Stated that there had been no new occurrence or material change in the risk of fluctuations in the market prices of investment securities or impairment. - FY2019-Q2RestatedAnnual report
「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
Stated that there had been no new occurrence or material change in the risk of fluctuations in the market prices of investment securities or impairment. - FY2019-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
Stated that there had been no new occurrence or material change in the risk of fluctuations in the market prices of investment securities or impairment. - FY2018RestatedAnnual report
「Investment securities consist mainly of shares in companies with which the Group has business relationships. Those with quoted market values are exposed to the risk of fluctuations in market prices, while those without quoted market values are exposed to the risk of impairment depending on the investee's operating results and other factors.」
Reiterated the risk of fluctuations in the market prices of investment securities and impairment resulting from the investees' operating results and other factors. - FY2018-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
Stated that there had been no new occurrence or material change in the risk of fluctuations in the market prices of investment securities or impairment. - FY2018-Q2RestatedAnnual report
「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
Stated that there had been no new occurrence or material change in the risk of fluctuations in the market prices of investment securities or impairment. - FY2018-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
Stated that there had been no new occurrence or material change in the risk of fluctuations in the market prices of investment securities or impairment. - FY2017First statedAnnual report
「Investment securities consist mainly of shares in companies with which the Group has business relationships. Those with quoted market values are exposed to the risk of fluctuations in market prices, while those without quoted market values are exposed to the risk of impairment depending on the investee's operating results and other factors.」
Identified fluctuations in market prices and impairment resulting from the investees' operating results and other factors as financial risks associated with shares in related companies.